Form D · Other Health Care
Healthspan Labs Inc.
Vancouver, A1 · CIK 0002026371
Offering snapshot reported Jun 17, 2024 · SEC filing
- Reported sold
- $221K Offering amount: $221K
- Investors reported
- 8 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Mar 15, 2024 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 17, 2024 | Initial | $220,750 | No comparison | 8 | SEC filing |
Offering details
- Securities
- Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-516181
Source: Form D, filed Jun 17, 2024. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Rex Farrand | Director, Executive |
| Bradley Jawl | Director, Executive |
| Zia Poonja | Director, Executive |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
1055 Dunsmuir Street, Suite 3000
Vancouver, A1, V7X 1K8
Vancouver, A1, V7X 1K8